LOCALLY ADVANCED/METASTATIC SOLID TUMOR
Clinical trials for LOCALLY ADVANCED/METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED/METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED/METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug INV-6452 targets Hard-to-Treat breast cancers
Disease control Recruiting nowThis study tests an experimental drug called INV-6452 in adults with advanced breast cancer (HR+/HER2-) or other solid tumors that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 201 participants wil…
Matched conditions: LOCALLY ADVANCED/METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for advanced cancer patients: first human trial of SIM0609 begins
Disease control Recruiting nowThis early-phase study tests a new drug called SIM0609 in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 232 participants will take part a…
Matched conditions: LOCALLY ADVANCED/METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC